Use of guideline‐recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence.

MLA

Janse, Roemer J., et al. “Use of Guideline‐recommended Medical Therapy in Patients with Heart Failure and Chronic Kidney Disease: From Physician’s Prescriptions to Patient’s Dispensations, Medication Adherence and Persistence.” European Journal of Heart Failure, vol. 24, no. 11, Nov. 2022, pp. 2185–95. EBSCOhost, https://doi.org/10.1002/ejhf.2620.

APA

Janse, R. J., Fu, E. L., Dahlström, U., Benson, L., Lindholm, B., van Diepen, M., Dekker, F. W., Lund, L. H., Carrero, J., & Savarese, G. (2022). Use of guideline‐recommended medical therapy in patients with heart failure and chronic kidney disease: from physician’s prescriptions to patient’s dispensations, medication adherence and persistence. European Journal of Heart Failure, 24(11), 2185–2195. https://doi.org/10.1002/ejhf.2620

Chicago

Janse, Roemer J., Edouard L. Fu, Ulf Dahlström, Lina Benson, Bengt Lindholm, Merel van Diepen, Friedo W. Dekker, Lars H. Lund, Juan‐Jesus Carrero, and Gianluigi Savarese. 2022. “Use of Guideline‐recommended Medical Therapy in Patients with Heart Failure and Chronic Kidney Disease: From Physician’s Prescriptions to Patient’s Dispensations, Medication Adherence and Persistence.” European Journal of Heart Failure 24 (11): 2185–95. doi:10.1002/ejhf.2620.